Moderna, Merck breakthrough could usher in wave of cancer vaccines
mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say
Moderna and Merck’s mRNA Melanoma Vaccine Looks Like a Game Changer
Moderna, Merck vaccine cuts recurrence and spread of melanoma, raising new treatment hope
Moderna, Merck Say mRNA Vaccine Prevents Melanoma From Returning
Moderna and Merck Revive mRNA Hopes With Melanoma Success
Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial
Moderna reports first positive Phase 3 for mRNA neoantigen therapy in melanoma
Moderna, Merck Vaccine Succeeds in Preventing Melanoma From Returning
FDA approves Moderna's mRNA flu vaccine after initially refusing to review it
FDA advisors unanimously vote to approve Moderna's mRNA after agency drama
Moderna gets $50 million to develop mRNA Ebola vaccine against Bundibugyo | Amid a raging Ebola outbreak, officials “urgently accelerate development” of vaccines.
FDA reverses surprise rejection of Moderna's mRNA flu vaccine | President admin’s vaccine chief overruled FDA scientists to initially reject the shot.
FDA Reverses Decision and Agrees To Review Moderna's Flu Vaccine
Prasad overruled FDA staff to reject Moderna's flu vaccine application
Moderna Says FDA Refuses To Review Its Application for Experimental Flu Shot
Moderna says FDA refuses to review its application for experimental flu shot
mRNA cancer vaccine shows protection at 5-year follow-up, Moderna and Merck say
Moderna Curbing Investments in Vaccine Trials Due To US Backlash, CEO Says
Moderna, the company that helped save the world, has unraveled
